Skip to main content

Table 1 Association between clinicopathological factors and SALL4 expression in ESCC patients

From: Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma

Parameters Number SALL4 expression P-value
  High group Low group
Age     
 ≥60 94 75 19 0.2594
 <60 39 27 12
Gender     
 Male 87 70 17 0.1965
 Female 46 32 14
Stage     
 I + IIa 92 66 26 0.0477 *
 IIb + III + IV 41 36 5
Tumor invasion     
 T1 + T2 64 46 18 0.2244
 T3 69 56 13
Lymph node metastasis
 N0 95 67 28 0.0068 **
 N1 + N2 38 35 3
Histological Grade     
 Well differentiated 33 23 10 0.0648
 Moderately differentiated 78 58 20
 Poorly differentiated 22 21 1
  1. * P <0.05, ** P <0.01